Quest Diagnostics earns FDA breakthrough designation for ade

Quest Diagnostics has been granted a breakthrough device designation from the FDA for its adeno-associated virus test.

Related Keywords

, Quest Diagnostics , Sarepta Therapeutic , Fda , Adeno Associated Virus , Pest , Sarepta Therapeutics , Elevidys , Gene Therapy , Duchenne Muscular Dystrophy , Collaboration , Clinical Lab Testing ,